Issue 8, 2012

Fabrication, characterisation and biological activity of phlorotannin-conjugated PCL/β-TCP composite scaffolds for bone tissue regeneration

Abstract

In general, a biomedical scaffold should have a three-dimensional (3D) shape that is structurally and mechanically equivalent to the replaced tissue, and afford biologically attractive sites for the injected cells to attach, proliferate and differentiate. In this study, we designed composite scaffolds consisting of poly(ε-caprolactone) (PCL), β-tricalcium phosphate (β-TCP), and phlorotannin fabricated by a combined melt-plotting and coating system for bone tissue regeneration. The pore size and porosity of the multilayered composite scaffolds were fixed at 300 μm and 55%, respectively. Phlorotannin, which exists in brown algae, has been reported to have several biological growth factors for tissue regeneration. However, phlorotannin has not been investigated in terms of cellular activity at various compositions in a 3D pore structure. The effect of phlorotannin composition (1, 3, and 5 wt%) on various physical characteristics including the surface roughness, water-absorption ability, and mechanical properties was investigated. Based on water absorption, the phlorotannin in the composite scaffolds induced marked wettability compared to the PCL/β-TCP composite scaffold. The in vitro biocompatibilities of the composites were examined using osteoblast-like cells (MG63). Initial cell attachment, cell viability, alkaline phosphatase (ALP) activity, and mineralisation were assessed. Based on scanning electron microscope (SEM) images, the cells were more highly packed and grew on the surface of the PCL/β-TCP/phlorotannin composites. Furthermore, the PCL/β-TCP/phlorotannin composites showed incredibly higher initial cell attachment than the PCL/β-TCP composite, and high cell viability (>2-fold) and ALP activity (>2-fold) were observed compared to the PCL/β-TCP composite. Based on these results, phlorotannin could be demonstrated to be a good supplemental bioactive agent for enhancing the bone tissue growth of PCL/β-TCP composite scaffolds.

Graphical abstract: Fabrication, characterisation and biological activity of phlorotannin-conjugated PCL/β-TCP composite scaffolds for bone tissue regeneration

Article information

Article type
Paper
Submitted
22 Sep 2011
Accepted
09 Dec 2011
First published
13 Jan 2012

J. Mater. Chem., 2012,22, 3568-3577

Fabrication, characterisation and biological activity of phlorotannin-conjugated PCL/β-TCP composite scaffolds for bone tissue regeneration

M. Yeo, W. Jung and G. Kim, J. Mater. Chem., 2012, 22, 3568 DOI: 10.1039/C2JM14725D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements